• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MPO
Click for more information
0.00% 14.0¢

MOLOPO ENERGY LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MPO
Ann: Becoming a substantial holder 		26/03/19 0 93
26/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  93 
MPO
Ann: Correction to December 2018 quarterly activities report 		08/02/19 0 256
08/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  256 
MPO
Ann: Quarterly Activities Report 		04/02/19 0 167
04/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  167 
MPO
Ann: ABW: Valuation of Molopo Energy Limited Update 		01/02/19 0 156
01/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  156 
MPO
Ann: AIB: Valuation of Molopo Energy Limited Update 		01/02/19 0 124
01/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  124 
MPO
Ann: Quarterly Cashflow Report 		31/01/19 0 95
31/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  95 
MPO
Ann: December 2018 quarterly activities report delayed release 		31/01/19 0 98
31/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  98 
MPO
Ann: June 2018 financial statements 		10/01/19 5 2.3K
10/01/19 Last post  Gekkko Comments Created with Sketch.  5  Views Created with Sketch.  2.3K 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.